These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6684674)

  • 21. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta.
    Su YH; Oakes JE; Lausch RN
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2325-32. PubMed ID: 8245849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections.
    Pinto AJ; Morahan PS; Brinton M; Stewart D; Gavin E
    J Interferon Res; 1990 Jun; 10(3):293-8. PubMed ID: 1696607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid recombinant human leukocyte interferon inhibits differentiation in murine B-16 melanoma cells.
    Fisher PB; Hermo H; Prignoli DR; Weinstein IB; Pestka S
    Biochem Biophys Res Commun; 1984 Feb; 119(1):108-15. PubMed ID: 6704115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine secretion of interferon-alpha/beta and tumour necrosis factor-alpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2.
    Ellermann-Eriksen S
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2191-9. PubMed ID: 8409942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody.
    Kumano Y; Yamamoto M; Mori R
    Antiviral Res; 1987 Jun; 7(5):289-301. PubMed ID: 2821897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
    Noisakran S; Campbell IL; Carr DJ
    J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of treatment regimen of interferon as an antitumor agent.
    Lee SH; Chiu H; Rinderknecht E; Sabo W; Stebbing N
    Cancer Res; 1983 Sep; 43(9):4172-5. PubMed ID: 6347366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
    Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P
    Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.
    Renton KW; Singh G; Stebbing N
    Biochem Pharmacol; 1984 Dec; 33(23):3899-902. PubMed ID: 6508841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
    Mester JC; Pitha PM; Glorioso JC
    Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell and virus sensitivity studies with recombinant human alpha interferons.
    Kramer MJ; Dennin R; Kramer C; Jones G; Connell E; Rolon N; Gruarin A; Kale R; Trown PW
    J Interferon Res; 1983; 3(4):425-35. PubMed ID: 6323591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
    Parr MB; Parr EL
    Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice.
    Vagvala SP; Thebeau LG; Wilson SR; Morrison LA
    J Virol; 2009 Jan; 83(2):953-60. PubMed ID: 18987142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness.
    Duerst RJ; Morrison LA
    Virology; 2004 Apr; 322(1):158-67. PubMed ID: 15063125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linkage of the early in vitro alpha/beta interferon response of mouse peritoneal macrophages to herpes simplex virus type 2.
    Ellermann-Eriksen S; Liberto MC; Iannello D; Mogensen SC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1025-33. PubMed ID: 3011968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection.
    Palliser D; Chowdhury D; Wang QY; Lee SJ; Bronson RT; Knipe DM; Lieberman J
    Nature; 2006 Jan; 439(7072):89-94. PubMed ID: 16306938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI; Bourne N
    J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.
    Weck PK; Apperson S; May L; Stebbing N
    J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.